This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tanaka, T. Articles by Okada, Y. Search for Related Content PubMed PubMed Citation Articles by Tanaka, T. Articles by Okada, Y.

A Novel Form of Prostate-specific Antigen Transcript Produced by Alternative Splicing¹

Department of Urology [T. T., T. Yo., T. Yu., Y. O.] and Central Research Laboratory [T. I.], Shiga University of Medical Science, Shiga 520-2192, Japan

Molecular characterization of prostate-specific antigen (PSA) has not been well elucidated, despite a great deal of clinical study. We examined the heterogeneity of PSA using reverse transcription-PCR and direct sequencing. A novel, alternatively spliced variant of the PSA transcript was found in prostate cancer (PC), as well as in benign prostatic tissue. This alternative splicing leads to the deletion of 44 amino acid residues (amino acids 45–88) from mature PSA, resulting in the loss of asparagine 45, which is a binding site for a carbohydrate chain. By these nested reverse transcription-PCR systems, this novel, alternatively spliced PSA gene was recognized in 13 of 18 (72.2%) cases with noncancerous prostate tissue, 4 of 5 (80.0%) PC cases, and 3 of 12 (25.0%) blood samples from PC patients (noncancerous prostate tissue group versus blood sample group, P = 0.011). At present, the biological significance of this alternative splicing remains to be established.

This article has been cited by other articles:

				I. P. Michael, L. Kurlender, N. Memari, G. M. Yousef, D. Du, L. Grass, C. Stephan, K. Jung, and E. P. Diamandis Intron Retention: A Common Splicing Event within the Human Kallikrein Gene Family Clin. Chem., March 1, 2005; 51(3): 506 - 515. [Abstract] [Full Text] [PDF]

				K. Jung, J. Reiche, A. Boehme, C. Stephan, S. A. Loening, D. Schnorr, W. Hoesel, and P. Sinha Analysis of Subforms of Free Prostate-Specific Antigen in Serum by Two-Dimensional Gel Electrophoresis: Potential to Improve Diagnosis of Prostate Cancer Clin. Chem., December 1, 2004; 50(12): 2292 - 2301. [Abstract] [Full Text] [PDF]

				C. A. Borgono, I. P. Michael, and E. P. Diamandis Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer Mol. Cancer Res., May 1, 2004; 2(5): 257 - 280. [Abstract] [Full Text] [PDF]

				T. Isono, T. Tanaka, S. Kageyama, and T. Yoshiki Structural Diversity of Cancer-related and Non-Cancer-related Prostate-specific Antigen Clin. Chem., December 1, 2002; 48(12): 2187 - 2194. [Abstract] [Full Text] [PDF]

				A. David, N. Mabjeesh, I. Azar, S. Biton, S. Engel, J. Bernstein, J. Romano, Y. Avidor, T. Waks, Z. Eshhar, et al. Unusual Alternative Splicing within the Human Kallikrein Genes KLK2 and KLK3 Gives Rise to Novel Prostate-specific Proteins J. Biol. Chem., May 10, 2002; 277(20): 18084 - 18090. [Abstract] [Full Text] [PDF]

				Y. Dong, A. Kaushal, L. Bui, S. Chu, P. J. Fuller, J. Nicklin, H. Samaratunga, and J. A. Clements Human Kallikrein 4 (KLK4) Is Highly Expressed in Serous Ovarian Carcinomas Clin. Cancer Res., August 1, 2001; 7(8): 2363 - 2371. [Abstract] [Full Text] [PDF]

				G. M. Yousef and E. P. Diamandis The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease Endocr. Rev., April 1, 2001; 22(2): 184 - 204. [Abstract] [Full Text]

				A. Magklara, A. Scorilas, D. Katsaros, M. Massobrio, G. M. Yousef, S. Fracchioli, S. Danese, and E. P. Diamandis The Human KLK8 (Neuropsin/Ovasin) Gene: Identification of Two Novel Splice Variants and Its Prognostic Value in Ovarian Cancer Clin. Cancer Res., April 1, 2001; 7(4): 806 - 811. [Abstract] [Full Text]